Erick Lucera
2021 - AVEO Pharmaceuticals
In 2021, Erick Lucera earned a total compensation of $1.2M as Chief Financial Officer at AVEO Pharmaceuticals, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,120 |
|---|---|
| Option Awards | $718,570 |
| Salary | $374,000 |
| Other | $8,094 |
| Total | $1,242,784 |
Lucera received $718.6K in option awards, accounting for 58% of the total pay in 2021.
Lucera also received $142.1K in non-equity incentive plan, $374K in salary and $8.1K in other compensation.
Rankings
In 2021, Erick Lucera's compensation ranked 7,988th out of 12,406 executives tracked by ExecPay. In other words, Lucera earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,988 out of 12,406 | 36th |
Division Manufacturing | 3,527 out of 5,494 | 36th |
Major group Chemicals And Allied Products | 1,566 out of 2,369 | 34th |
Industry group Drugs | 1,391 out of 2,090 | 33rd |
Industry Pharmaceutical Preparations | 1,030 out of 1,537 | 33rd |
Pay ratio
| Erick Lucera's Pay | $1,242,784 |
|---|---|
| Median Employee's Pay | $278,596 |
| Pay Ratio | 4to 1 |
In 2021, the annual total compensation of Erick Lucera was $1,242,784.
The annual total compensation of the median employee at AVEO Pharmaceuticals was $278,596.
The ratio of Erick Lucera's pay to the pay of median employee was therefore 4 to one.
Source: SEC filing on April 26, 2022.
Lucera's colleagues
We found three more compensation records of executives who worked with Erick Lucera at AVEO Pharmaceuticals in 2021.